Dr. Larry Norton:
Well, we mean, it depends on a chemotherapy they received. With some chemotherapies, there is a somewhat increasing risk of some bad effects. With other chemotherapies, such as a one we have been regulating during Memorial Sloan Kettering, that is a CMF combination, there’s no justification of long-term toxicity.
So there’s some movement in that regard. But a risks are really small. The long-term risks are really small. And a people that we have oral to who, in this trial, randomized to get chemotherapy are feeling good about these results, since they had a chemotherapy. They’re disease-free. It hasn’t harm them.
But they have helped thousands and thousands of other women. Maybe 100,000 women per year, in a United States alone, are going to advantage from these results. And people are really altruistic. The volunteers in this hearing are altruists. They’re genuine heroes.
And they have done a large grant to assisting people with cancer via a world.